Meredith R F, Eisert D R, Kaka Z, Hodgson S E, Johnston G A, Boutselis J G
Cancer. 1986 Nov 1;58(9):2003-7. doi: 10.1002/1097-0142(19861101)58:9<2003::aid-cncr2820580908>3.0.co;2-2.
The Ohio State University Registry recorded 1208 uterine corpus malignancies between 1940 and 1983. Thirty cases occurred in women with a history of pelvic irradiation. Eight patients had previously been irradiated for pelvic malignancy, four of whom presented with advanced stage sarcomas and died of their disease within 14 months. This represents an increase over the expected sarcoma prevalence which is less than 5%. In contrast, the majority of women (20 of 22) previously irradiated for benign conditions were diagnosed with endometrial adenocarcinoma. In 18, the adenocarcinoma was diagnosed as Stage I, and the prognosis was only slightly less favorable than for nonirradiated women. No significant effect of age at the time of irradiation was apparent. This study of women with a history of pelvic irradiation who later developed uterine cancer demonstrates a tendency for patients previously irradiated for pelvic malignancy to present with advanced stage, extremely aggressive uterine tumors compared to those previously irradiated for benign conditions.
俄亥俄州立大学登记处记录了1940年至1983年间1208例子宫体恶性肿瘤病例。30例发生在有盆腔放疗史的女性中。8例患者曾因盆腔恶性肿瘤接受过放疗,其中4例出现晚期肉瘤,并在14个月内死于该病。这一比例高于预期的肉瘤患病率,预期患病率低于5%。相比之下,大多数(22例中的20例)曾因良性疾病接受放疗的女性被诊断为子宫内膜腺癌。其中18例腺癌被诊断为I期,其预后仅比未接受放疗的女性略差。放疗时的年龄没有明显的显著影响。这项对有盆腔放疗史且后来患子宫癌的女性的研究表明,与那些曾因良性疾病接受放疗的患者相比,曾因盆腔恶性肿瘤接受放疗的患者倾向于出现晚期、极具侵袭性的子宫肿瘤。